Rydex Funds Fund Family Report
 | 

  • Select a Fund Family

    • Performance
    04-30-13

    Total ReturnCategory Average
    Total Return35.1816.362.2614.609.08
    Category Average23.0011.881.0810.377.16
    Assets for Each Yr*4.585.094.184.134.97
    *billions

    Trailing Returns %
    04-30-13

      YTD 3 Year 5 Year    
    Fund Family 9.08 12.24 11.58

    Key Stats
    04-30-13

    Total Assets* Min. Investment Load (% of Assets) No Load (% of Assets)
    $4,973 mil $2,500 12.75 87.25
    Asset Class Score % of Assets Expense Ratio % Expense Rating
    Domestic Stock -- 43.02 1.79 Above Avg
    International Stock -- 0.58 1.83 Above Avg
    Municipal Bond -- -- -- --
    Taxable Bond -- 18.68 1.50 Above Avg
    *Doesn't include money market assets.

    Top 20 US Holdings | Get Price Quotes
    05-23-13

      Sector YTD Return % % Net Assets  
    Apple Inc* Technology -15.85 1.90
    Microsoft Corporation* Technology 29.58 1.25
    Google, Inc. Class A* Technology 24.80 1.02
    Gilead Sciences Inc* Healthcare 51.07 0.86
    Amgen Inc* Healthcare 23.62 0.86
    Oracle Corporation* Technology 2.73 0.69
    Biogen Idec Inc* Healthcare 58.93 0.67
    Celgene Corporation* Healthcare 57.56 0.62
    Intel Corp* Technology 18.82 0.56
    Amazon.com Inc* Consumer Cyclical 4.36 0.54
    Cisco Systems Inc* Technology 20.51 0.53
    Qualcomm, Inc.* Technology 3.72 0.50
    Regeneron Pharmaceuticals, Inc.* Healthcare 48.99 0.48
    Vertex Pharmaceuticals* Healthcare 87.30 0.47
    Comcast Corp Class A* Communication Services 12.46 0.44
    Mondelez International Inc* Consumer Defensive 23.21 0.40
    Procter & Gamble Co* Consumer Defensive 17.64 0.37
    Alexion Pharmaceuticals, Inc.* Healthcare 6.55 0.34
    Coca-Cola Co* Consumer Defensive 16.44 0.34
    Philip Morris International, Inc* Consumer Defensive 13.77 0.33

    Best 5-Year Relative Performance | More
    05-23-13

    Fund Name 5-Yr Rank Analyst Report  
    Rydex S&P MidCap 400 Pure Gr 2 --
    Rydex Dynamic NASDAQ-100 2X 3 --
    Rydex S&P 500 Pure Growth C 6 --
    Rydex NASDAQ-100 Inv 7 05-15-09
    Rydex Biotechnology Adv 9 --

    Worst 5-Year Relative Performance | More
    05-23-13

    Fund Name 5-Yr Rank Analyst Report  
    Rydex Japan 2x Strategy A 100 --
    Rydex S&P MidCap 400 Pure Va 97 --
    Rydex Electronics Inv 96 --
    Rydex Europe 1.25x Strategy 96 --
    Rydex Russell 2000 2x Strate 96 --

    Lowest Expenses | More
    05-23-13

    Fund Name Expense Ratio Analyst Report  
    Rydex Govt Long Bond 1.2x St 0.95 --
    Rydex Nova Inv 1.26 --
    Rydex Precious Metals Inv 1.26 --
    Rydex NASDAQ-100 Inv 1.27 05-15-09
    Rydex Financial Services Inv 1.34 --

    Highest Expenses | More
    05-23-13

    Fund Name Expense Ratio Analyst Report  
    Rydex Dow 2x Strategy C 2.54 --
    Rydex Inverse Dow 2x Strateg 2.53 --
    Rydex Inverse Russell 2000 S 2.51 --
    Rydex Inverse Mid Cap Strate 2.42 --
    Rydex Real Estate C 2.36 --

    Longest Manager Tenure | More
    05-23-13

    Fund Name   Manager Name Avg Manager Tenure  
    Rydex NASDAQ-100 Inv Michael P. Byrum 9.40
    Rydex Technology Inv Michael P. Byrum 9.30
    Rydex Banking Adv Michael P. Byrum 9.10
    Rydex Basic Material Michael P. Byrum 9.10
    Rydex Biotechnology Michael P. Byrum 9.10

    Shortest Manager Tenure | More
    05-23-13

    Fund Name   Manager Name Avg Manager Tenure  
    Rydex Emerging Marke Michael P. Byrum 2.60
    Rydex Inverse Emergi Michael P. Byrum 2.60
    Rydex High Yield Str Michael P. Byrum 5.00
    Rydex Japan 2x Strat Michael P. Byrum 5.20
    Rydex Inverse High Y Michael P. Byrum 5.80